세계의 인공 심장 시장 : 제품, 재료, 용도, 최종 사용자별 예측(2025-2030년)

The Artificial Heart Market was valued at USD 2.54 billion in 2023, expected to reach USD 2.82 billion in 2024, and is projected to grow at a CAGR of 11.27%, to USD 5.37 billion by 2030.

The market for artificial hearts, defined as mechanical devices that replace the function of a failing human heart, is driven by increasing incidences of cardiovascular diseases, advancements in medical technology, and a growing aging population demanding effective solutions for heart failure. Essential in cases where heart transplants are not viable, artificial hearts serve as a bridge-to-transplant or permanent solution. Key applications include use in patients with chronic heart diseases, reducing the mortality rate and improving patient life quality. The market end-users span hospitals, specialty cardiac care centers, and ambulatory surgical centers.

A surge in healthcare investment and favorable government policies are influential growth factors. Additionally, technological advancements in biomaterials and electronics, enhanced healthcare infrastructure, and a rising awareness regarding heart-related complications propel market growth. Emerging opportunities lie in the integration of artificial intelligence, harnessing IoT in device monitoring, and personalized medicine to enhance patient-specific treatment plans. However, challenges such as high costs of devices, regulatory hurdles, and lack of skilled professionals restrain market expansion. Moreover, issues like device malfunction risks and limited availability in developing regions highlight potential constraints.

For business growth, innovation in biodegradable materials to increase biocompatibility and reduce immune rejection, miniaturization techniques, and development of wireless charging technology for internal devices are key areas of research. Collaborations between biotech firms and universities for cutting-edge R&D, along with strategic mergers and acquisitions, can enhance competitive positioning. Given the market's evolving nature, emphasis should also be placed on market penetration strategies in emerging economies while addressing cost variability and improving patient education on the benefits of artificial hearts. Insightful investments in these areas will likely yield significant returns, capitalizing on the widening acceptance and technological advancements within the artificial heart industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Heart Market

The Artificial Heart Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cardiovascular diseases worldwide leading to increased demand for artificial heart solutions
  • Continuous advancements in artificial heart technology and improved clinical outcomes driving market growth
  • Increased healthcare spending and supportive government policies promoting development and adoption of artificial hearts
  • Rising geriatric population with higher susceptibility to heart diseases boosting artificial heart market expansion
• Market Restraints
  • Limited availability of suitable donor organs significantly affects market growth for artificial heart devices
  • Technical and engineering challenges in artificial heart development impact reliability and market satisfaction
• Market Opportunities
  • Expansion of personalized artificial heart solutions through 3D printing and customization
  • Collaboration with healthcare providers to establish data-driven postoperative artificial heart care programs
  • Implementation of AI and machine learning for predictive maintenance and optimization of artificial heart functions
• Market Challenges
  • Comprehensive web crawl to gather information on market challenges
  • Comprehensive web crawl to gather information on industry-specific market challenges

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Heart Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Heart Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Heart Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Heart Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Heart Market

A detailed market share analysis in the Artificial Heart Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Heart Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Heart Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Heart Market

A strategic analysis of the Artificial Heart Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Heart Market, highlighting leading vendors and their innovative profiles. These include ALung Technologies, Asahi Kasei Corporation, Baxter International Inc., Boston Scientific Corporation, CytoSorbents Corporation, Getinge AB, Henry Schein, Inc., LivaNova PLC, Merit Medical Systems, MicroPort Scientific Corporation, Nipro Corporation, NuPulseCV, Pfizer Inc., Procyrion Inc., Spectranetics, TandemLife, Terumo Corporation, Transonic Systems Inc, Zimmer Biomet Holdings, and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Artificial Heart Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Total Artificial Heart and Ventricular Assist Devices.
• Based on Material, market is studied across Biological Materials and Synthetic Materials. The Biological Materials is further studied across Biomimetic materials and Tissue-engineered materials. The Synthetic Materials is further studied across Ceramics, Metals, and Polymers.
• Based on Application, market is studied across Bridge to Recovery, Bridge to Transplantation, and Destination Therapy.
• Based on End-User, market is studied across Hospitals and Specialized Cardiac Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cardiovascular diseases worldwide leading to increased demand for artificial heart solutions
    • 5.1.1.2. Continuous advancements in artificial heart technology and improved clinical outcomes driving market growth
    • 5.1.1.3. Increased healthcare spending and supportive government policies promoting development and adoption of artificial hearts
    • 5.1.1.4. Rising geriatric population with higher susceptibility to heart diseases boosting artificial heart market expansion
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of suitable donor organs significantly affects market growth for artificial heart devices
    • 5.1.2.2. Technical and engineering challenges in artificial heart development impact reliability and market satisfaction
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of personalized artificial heart solutions through 3D printing and customization
    • 5.1.3.2. Collaboration with healthcare providers to establish data-driven postoperative artificial heart care programs
    • 5.1.3.3. Implementation of AI and machine learning for predictive maintenance and optimization of artificial heart functions
  • 5.1.4. Challenges
    • 5.1.4.1. Comprehensive web crawl to gather information on market challenges
    • 5.1.4.2. Comprehensive web crawl to gather information on industry-specific market challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Utilization of total artificial heart device for biventricular heart failure patients
  • 5.2.2. End-Users: Growing demand of artificial heart in specialized cardiac center for personalized and intensive patient care
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Heart Market, by Product

• 6.1. Introduction
• 6.2. Total Artificial Heart
• 6.3. Ventricular Assist Devices

7. Artificial Heart Market, by Material

• 7.1. Introduction
• 7.2. Biological Materials
  • 7.2.1. Biomimetic materials
  • 7.2.2. Tissue-engineered materials
• 7.3. Synthetic Materials
  • 7.3.1. Ceramics
  • 7.3.2. Metals
  • 7.3.3. Polymers

8. Artificial Heart Market, by Application

• 8.1. Introduction
• 8.2. Bridge to Recovery
• 8.3. Bridge to Transplantation
• 8.4. Destination Therapy

9. Artificial Heart Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Specialized Cardiac Centers

10. Americas Artificial Heart Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Artificial Heart Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Heart Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Everstone capital to merge translumina therapeutics and everlife holdings, creating a USD 1 Billion healthcare giant ahead of IPO
  • 13.3.2. BiVACOR secures USD 13M MRFF grant to propel wireless-powered total artificial heart trials in 2024, targeting booming USD 86.6B cardiovascular market
  • 13.3.3. Carmat enhances aeson artificial heart with real-time safety software, targets improved patient safety and global market expansion
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ALung Technologies
• 2. Asahi Kasei Corporation
• 3. Baxter International Inc.
• 4. Boston Scientific Corporation
• 5. CytoSorbents Corporation
• 6. Getinge AB
• 7. Henry Schein, Inc.
• 8. LivaNova PLC
• 9. Merit Medical Systems
• 10. MicroPort Scientific Corporation
• 11. Nipro Corporation
• 12. NuPulseCV
• 13. Pfizer Inc.
• 14. Procyrion Inc.
• 15. Spectranetics
• 16. TandemLife
• 17. Terumo Corporation
• 18. Transonic Systems Inc
• 19. Zimmer Biomet Holdings
• 20. Zoll Medical Corporation